世界の筋萎縮性側索硬化症（ルーゲーリック病）治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0301
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、90ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、筋萎縮性側索硬化症（ルーゲーリック病）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、幹細胞治療）、用途別市場規模（病院、診断センター、クリニック、小売薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・筋萎縮性側索硬化症（ルーゲーリック病）治療の市場動向
・企業の競争状況、市場シェア
・筋萎縮性側索硬化症（ルーゲーリック病）治療の種類別市場規模（化学療法、幹細胞治療）
・筋萎縮性側索硬化症（ルーゲーリック病）治療の用途別市場規模（病院、診断センター、クリニック、小売薬局）
・筋萎縮性側索硬化症（ルーゲーリック病）治療の北米市場規模2016-2027（アメリカ、カナダ）
・筋萎縮性側索硬化症（ルーゲーリック病）治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・筋萎縮性側索硬化症（ルーゲーリック病）治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・筋萎縮性側索硬化症（ルーゲーリック病）治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・筋萎縮性側索硬化症（ルーゲーリック病）治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（GNT Pharma、Amkor Pharma、Synthetic Biologics、Mitsubishi Tanabe Pharma、Avicena、Sanofi）
・結論

Amyotrophic Lateral Sclerosis (ALS) is a neurological disease that affects nerve cells in the brain and spinal cords which controls the activity of voluntary muscles. It is also termed as Lou Gehrig’s disease. There are several causes behind ALS which includes gene mutation, disorganized immune response, chemical imbalance etc. The symptoms for ALS mainly include fasciculation, respiratory problems, muscles weakness and cramps. The mortality rate in the ALS patients in high due to breathing problem.
Increasing in the number of patients affected with ALS is one of the major factor to drive the growth of ALS treatment market. Sporadic and familial are two types of ALS disease, in which sporadic disease is most common disease found with 90–95% of the overall cases in US and the government initiatives to examination the research for rare disease and FDA approvals creates an opportunity for various market players due to which the global market of amyotrophic lateral sclerosis treatment is expected to expand at healthy CAGR during the forecast period. Due to lower prevalence rate, awareness about the disease and low treatment availability hinder the growth of ALS treatment market.

Market Analysis and Insights: Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market
The global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment market.

Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Scope and Market Size
Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Chemotherapy
Stem Cell Therapy

Segment by Application
Hospitals
Diagnostic Centres
Clinics
Retail Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GNT Pharma
Amkor Pharma
Synthetic Biologics
Mitsubishi Tanabe Pharma
Avicena
Sanofi

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Stem Cell Therapy
1.3 Market by Application
1.3.1 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Diagnostic Centres
1.3.4 Clinics
1.3.5 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Perspective (2016-2027)
2.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Growth Trends by Regions
2.2.1 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Industry Dynamic
2.3.1 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Trends
2.3.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Drivers
2.3.3 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Challenges
2.3.4 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Players by Revenue
3.1.1 Global Top Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Players by Revenue (2016-2021)
3.1.2 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue
3.4 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Concentration Ratio
3.4.1 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue in 2020
3.5 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Key Players Head office and Area Served
3.6 Key Players Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Product Solution and Service
3.7 Date of Enter into Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Breakdown Data by Type
4.1 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Historic Market Size by Type (2016-2021)
4.2 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Forecasted Market Size by Type (2022-2027)

5 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Breakdown Data by Application
5.1 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Historic Market Size by Application (2016-2021)
5.2 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2016-2027)
6.2 North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type
6.2.1 North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2016-2021)
6.2.2 North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2022-2027)
6.2.3 North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2016-2027)
6.3 North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application
6.3.1 North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2016-2021)
6.3.2 North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2022-2027)
6.3.3 North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2016-2027)
6.4 North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country
6.4.1 North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2016-2021)
6.4.2 North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2016-2027)
7.2 Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type
7.2.1 Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2016-2021)
7.2.2 Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2022-2027)
7.2.3 Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2016-2027)
7.3 Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application
7.3.1 Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2016-2021)
7.3.2 Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2022-2027)
7.3.3 Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2016-2027)
7.4 Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country
7.4.1 Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2016-2021)
7.4.2 Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2016-2027)
8.2 Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type
8.2.1 Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application
8.3.1 Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Region
8.4.1 Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2016-2027)
9.2 Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type
9.2.1 Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2016-2027)
9.3 Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application
9.3.1 Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2016-2027)
9.4 Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country
9.4.1 Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2016-2027)
10.2 Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type
10.2.1 Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application
10.3.1 Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country
10.4.1 Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GNT Pharma
11.1.1 GNT Pharma Company Details
11.1.2 GNT Pharma Business Overview
11.1.3 GNT Pharma Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction
11.1.4 GNT Pharma Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2016-2021)
11.1.5 GNT Pharma Recent Development
11.2 Amkor Pharma
11.2.1 Amkor Pharma Company Details
11.2.2 Amkor Pharma Business Overview
11.2.3 Amkor Pharma Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction
11.2.4 Amkor Pharma Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2016-2021)
11.2.5 Amkor Pharma Recent Development
11.3 Synthetic Biologics
11.3.1 Synthetic Biologics Company Details
11.3.2 Synthetic Biologics Business Overview
11.3.3 Synthetic Biologics Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction
11.3.4 Synthetic Biologics Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2016-2021)
11.3.5 Synthetic Biologics Recent Development
11.4 Mitsubishi Tanabe Pharma
11.4.1 Mitsubishi Tanabe Pharma Company Details
11.4.2 Mitsubishi Tanabe Pharma Business Overview
11.4.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction
11.4.4 Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2016-2021)
11.4.5 Mitsubishi Tanabe Pharma Recent Development
11.5 Avicena
11.5.1 Avicena Company Details
11.5.2 Avicena Business Overview
11.5.3 Avicena Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction
11.5.4 Avicena Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2016-2021)
11.5.5 Avicena Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction
11.6.4 Sanofi Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2016-2021)
11.6.5 Sanofi Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Stem Cell Therapy
Table 4. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Regions (2016-2021)
Table 8. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Regions (2022-2027)
Table 10. Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Trends
Table 11. Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Drivers
Table 12. Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Challenges
Table 13. Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Restraints
Table 14. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Players (2016-2021)
Table 16. Global Top Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment as of 2020)
Table 17. Ranking of Global Top Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Product Solution and Service
Table 21. Date of Enter into Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. GNT Pharma Company Details
Table 62. GNT Pharma Business Overview
Table 63. GNT Pharma Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Product
Table 64. GNT Pharma Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2016-2021) & (US$ Million)
Table 65. GNT Pharma Recent Development
Table 66. Amkor Pharma Company Details
Table 67. Amkor Pharma Business Overview
Table 68. Amkor Pharma Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Product
Table 69. Amkor Pharma Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2016-2021) & (US$ Million)
Table 70. Amkor Pharma Recent Development
Table 71. Synthetic Biologics Company Details
Table 72. Synthetic Biologics Business Overview
Table 73. Synthetic Biologics Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Product
Table 74. Synthetic Biologics Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2016-2021) & (US$ Million)
Table 75. Synthetic Biologics Recent Development
Table 76. Mitsubishi Tanabe Pharma Company Details
Table 77. Mitsubishi Tanabe Pharma Business Overview
Table 78. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Product
Table 79. Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2016-2021) & (US$ Million)
Table 80. Mitsubishi Tanabe Pharma Recent Development
Table 81. Avicena Company Details
Table 82. Avicena Business Overview
Table 83. Avicena Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Product
Table 84. Avicena Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2016-2021) & (US$ Million)
Table 85. Avicena Recent Development
Table 86. Sanofi Company Details
Table 87. Sanofi Business Overview
Table 88. Sanofi Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Product
Table 89. Sanofi Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2016-2021) & (US$ Million)
Table 90. Sanofi Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Features
Figure 3. Stem Cell Therapy Features
Figure 4. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Diagnostic Centres Case Studies
Figure 7. Clinics Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Report Years Considered
Figure 10. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Regions (2022-2027)
Figure 14. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Players in 2020
Figure 15. Global Top Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue in 2020
Figure 17. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Type (2016-2027)
Figure 21. North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Application (2016-2027)
Figure 22. North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Country (2016-2027)
Figure 23. United States Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Type (2016-2027)
Figure 27. Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Application (2016-2027)
Figure 28. Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Country (2016-2027)
Figure 29. Germany Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Region (2016-2027)
Figure 39. China Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. GNT Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2016-2021)
Figure 59. Amkor Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2016-2021)
Figure 60. Synthetic Biologics Revenue Growth Rate in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2016-2021)
Figure 61. Mitsubishi Tanabe Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2016-2021)
Figure 62. Avicena Revenue Growth Rate in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2016-2021)
Figure 63. Sanofi Revenue Growth Rate in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0301 2021年4月 90Pages
QYResearch社発行の本調査資料では、筋萎縮性側索硬化症（ルーゲーリック病）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、幹細胞治療）、用途別市場規模（病院、診断センター、クリニック、小売薬局）、主要地域別市場規模（北米、...

世界の筋萎縮性側索硬化症（ALS）治療市場規模・現状・予測（2021年-2027年）

Global Amyotrophic Lateral Sclerosis Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0303 2021年4月 90Pages
QYResearch社発行の本調査資料では、筋萎縮性側索硬化症（ALS）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬物療法、理学療法、言語療法、その他）、用途別市場規模（病院、専門センター、研究センター、その他）、主要地域別市場規模（...

世界の筋萎縮性側索硬化症（ALS）治療薬市場規模・現状・予測（2021年-2027年）

Global Amyotrophic Lateral Sclerosis Drugs Market Size, Status and Forecast 2021-2027
QYR2104Z0302 2021年4月 99Pages
QYResearch社発行の本調査資料では、筋萎縮性側索硬化症（ALS）治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（リルゾール、エダラボン（ラジカバ）、CoQ10、ブチルフタリド、その他）、用途別市場規模（病院薬局、小売薬局、オンライ...

世界の移植片対宿主病（GVHD）治療市場規模・現状・予測（2021年-2027年）

Global Graft Versus Host Disease (GVHD) Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2621 2021年4月 128Pages
QYResearch社発行の本調査資料では、移植片対宿主病（GVHD）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（モノクローナル抗体、MTOR阻害剤、チロシンキナーゼ阻害剤、サリドマイド、エタネルセプト）、用途別市場規模（急性移植片対宿...

世界の炎症性腸疾患（IBD）治療市場規模・現状・予測（2021年-2027年）

Global Inflammatory Bowel Disease (IBD) Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3158 2021年4月 94Pages
QYResearch社発行の本調査資料では、炎症性腸疾患（IBD）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（TNF阻害剤、アミノサリサイクレート、免疫調節剤、コルチコステロイド）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、...

世界の急性リンパ性白血病（ALL）治療市場規模・現状・予測（2021年-2027年）

Global Acute Lymphoid Leukemia Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0071 2021年4月 94Pages
QYResearch社発行の本調査資料では、急性リンパ性白血病（ALL）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、標的療法、放射線療法、骨髄移植、免疫療法、その他）、用途別市場規模（成人、子供）、主要地域別市場規模（北米、ア...

世界の多発性硬化症治療市場規模・現状・予測（2021年-2027年）

Global Multiple Sclerosis Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3956 2021年4月 93Pages
QYResearch社発行の本調査資料では、多発性硬化症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（免疫調節剤、免疫抑制剤）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界の腸疾患検査・治療市場規模・現状・予測（2021年-2027年）

Global Enteric Disease Testing and Therapeutic Market Size, Status and Forecast 2021-2027
QYR2104Z2195 2021年4月 95Pages
QYResearch社発行の本調査資料では、腸疾患検査・治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（細菌性疾患、ウイルス性疾患、寄生虫性疾患）、用途別市場規模（病院、研究）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、...

世界の進行性再発性多発性硬化症治療市場規模・現状・予測（2021年-2027年）

Global Progressive Relapsing Multiple Sclerosis Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4818 2021年4月 99Pages
QYResearch社発行の本調査資料では、進行性再発性多発性硬化症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（COG-133、GZ-402668、イネビリズマブ、VCE-0032、その他）、用途別市場規模（診療所、病院、その他）、主要...

世界のミトコンドリアミオパチー診断・治療市場規模・現状・予測（2021年-2027年）

Global Mitochondrial Myopathy Diagnosis & Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3824 2021年4月 94Pages
QYResearch社発行の本調査資料では、ミトコンドリアミオパチー診断・治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ミトコンドリアミオパチー診断、ミトコンドリアミオパチー治療）、用途別市場規模（病院、クリニック、疾病研究開発機関）、主...

世界の筋萎縮性側索硬化症（ルーゲーリック病）治療市場規模・現状・予測（2021年-2027年） Amyotrophic Lateral Sclerosis (ALS) is a neurological disease that affects nerve cells in the brain and spinal cords which controls the activity of voluntary muscles. It is also termed as Lou Gehrig’s disease. There are several causes behind ALS which includes gene mutation, disorganized immune resp…
世界の筋萎縮性側索硬化症（ALS）治療市場規模・現状・予測（2021年-2027年） Amyotrophic lateral sclerosis is a neurodegenerative disease. ALS affects the nerve cells in the brain and spinal cord that control the voluntary muscles. It is also known as the Lou Gehrig’s disease. Amyotrophic lateral sclerosis can be caused due to various factors such as genetics or environmenta…
世界の筋萎縮性側索硬化症（ALS）治療薬市場規模・現状・予測（2021年-2027年） Amyotrophic lateral sclerosis is a neurodegenerative disease. ALS affects the nerve cells in the brain and spinal cord that control the voluntary muscles. It is also known as the Lou Gehrig’s disease. Amyotrophic lateral sclerosis can be caused due to various factors such as genetics or environmenta…
世界の多発性硬化症幹細胞治療市場規模・現状・予測（2021年-2027年） Multiple sclerosis is a nervous system disease, triggered by unidentified environmental factors that adversely affects the brain and spinal cord. It damages the myelin sheath that surrounds and protects the nerve cells. Some of the symptoms of the disease includes weakness, numbness, blurred vision,…
世界の多発性硬化症幹細胞治療市場規模・現状・予測（2021年-2027年） Multiple sclerosis is a nervous system disease, triggered by unidentified environmental factors that adversely affects the brain and spinal cord. It damages the myelin sheath that surrounds and protects the nerve cells. Some of the symptoms of the disease includes weakness, numbness, blurred vision,…